Syngene International Ltd share price logo

Syngene International Ltd Share Price

(SYNGENE)

Small Cap

Healthcare Sector

₹726.2▲0.92%

as on 04:01PM, 28 Mar 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Option Chain

Syngene International Ltd Performance

  • Day's Low

    Day's High

    ₹716.3
    Day's Price Range
    ₹731.8

  • 52 Week's Low

    52 Week's High

    ₹607.65
    52-Week Price Range
    ₹960.6
1 Month Return+ 11.46 %
3 Month Return-15.41 %
1 Year Return+ 2.51 %
Previous Close₹719.55
Open₹724.00
Volume5.48L
Upper Circuit₹791.50
Lower Circuit₹647.60
Market Cap₹29,232.24Cr

Syngene International Ltd Fundamentals

P/E Ratio

58.1

PEG Ratio

446.89

Market Cap

₹29,232.24 Cr

P/B Ratio

6.73

EPS

12.69

Dividend Yield

0.18

Sector

Healthcare

ROE

11.95

Syngene International Ltd Analyst Rating

based on 10 analysts

BUY

60.00%

Buy

10.00%

Hold

30.00%

Sell

Based on 10 analysts offering long term price targets for Syngene International Ltd. An average target of ₹839.5

Source: S&P Global Market Intelligence

Syngene International Ltd Share analysis

Syngene International Ltd price forecast by 10 analysts

Upside of15.60%

High

₹1030

Target

₹839.50

Low

₹700

Syngene International Ltd target price ₹839.5, a slight upside of 15.6% compared to current price of ₹726.2. According to 10 analysts rating.

Source: S&P Global Market Intelligence

Key events for Syngene International Ltd

  • Syngene International Receives Positive BUY Recommendation - 27 Mar, 2025

    Syngene International is recommended as a BUY with a target price of Rs 875, indicating a 22% upside. The company is well-positioned in the pharmaceutical outsourcing market, leveraging its expertise in small molecules and biologics.

  • Syngene Expands Renewable Energy Investment - 25 Mar, 2025

    Syngene International Limited has announced a Rs 65 million investment in O2 Renewable Energy II Private Limited, increasing its stake to 33.79%. This strategic move aims to enhance renewable power consumption and aligns with Syngene's sustainability goals.

  • Syngene Faces Increased Tax Demand of Rs. 118.9 Crore - 24 Mar, 2025

    Syngene International Ltd. reported a revised tax demand of approximately Rs. 118.9 crore for the assessment year 2018-19. The company is analyzing the order and considering its next steps, which may affect its financial position.

  • Syngene Receives Tax Demand with No Impact - 23 Mar, 2025

    Syngene International Ltd. has received a tax demand notice of Rs 1.85 crore for the Assessment Year 2019-20, but it claims no material impact on its operations or financials.

  • Syngene Schedules Investor Meeting with Bandhan Mutual Fund - 19 Mar, 2025

    Syngene International Ltd. will hold a virtual investor meeting with Bandhan Mutual Fund on March 25, 2025, ensuring no unpublished price-sensitive information is disclosed. The company continues to focus on its role in the biotechnology sector.

  • Syngene International Releases Investor Presentation - 12 Mar, 2025

    Syngene International Limited released an investor presentation during a meeting on March 12, 2025. The presentation reiterated existing information, emphasizing the company's commitment to transparency and stakeholder communication.

  • Syngene Expands U.S. Operations with Major Investments - 11 Mar, 2025

    Syngene International has announced a $36.5 million acquisition of a biologics facility in the U.S. and plans to invest up to $56 million in its subsidiary, Syngene USA Inc. These strategic moves aim to strengthen Syngene's presence in the U.S. market and enhance its capabilities in biologics manufacturing.

  • Syngene Expands with First US Biologics Facility - 10 Mar, 2025

    Syngene International has acquired its first biologics manufacturing facility in the US for approximately $50 million. This strategic investment will enhance its capabilities in large molecule discovery and manufacturing, increasing single-use bioreactor capacity to 50,000 liters. The acquisition is expected to close in March 2025 and aims to strengthen Syngene's position in the human and animal health markets.

Insights on Syngene International Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 75.7 Cr → 131.1 Cr (in ₹), with an average increase of 23.9% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 13.58% to 15.40% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 6.74% to 6.80% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, SYNGENE stock has moved up by 0.9%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 839.8 Cr → 962.0 Cr (in ₹), with an average increase of 6.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Vimta Labs Ltd has given 217.7% return, outperforming this stock by 196.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Vimta Labs Ltd has given 121.0% return, outperforming this stock by 118.5%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 20.72% to 20.64% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 54.72% to 52.74% in Dec 2024 quarter

Syngene International Ltd Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹853.50Cr (-)₹916.90Cr (↑7.43%)₹789.70Cr (↓13.87%)₹891.00Cr (↑12.83%)₹943.70Cr (↑5.91%)
Net Income₹111.50Cr (-)₹188.60Cr (↑69.15%)₹75.70Cr (↓59.86%)₹106.10Cr (↑40.16%)₹131.10Cr (↑23.56%)
Net Profit Margin13.06% (-)20.57% (↑57.50%)9.59% (↓53.38%)11.91% (↑24.19%)13.89% (↑16.62%)
Value in ₹ crore
Details2021202220232024
Total Assets₹4,977.30Cr (-)₹5,686.00Cr (↑14.24%)₹5,970.10Cr (↑5.00%)₹5,962.40Cr (↓0.13%)
Total Liabilities₹2,159.00Cr (-)₹2,394.00Cr (↑10.88%)₹2,351.20Cr (↓1.79%)₹1,770.90Cr (↓24.68%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹677.40Cr (-)₹698.00Cr (↑3.04%)₹582.20Cr (↓16.59%)₹838.40Cr (↑44.01%)₹913.40Cr (↑8.95%)

Syngene International Ltd Index Inclusions

Nifty 500

₹21,339.55

-0.32 (▲-68.4%)

S&P BSE 250 LargeMidCap

₹10,029.73

-0.39 (▲-38.93%)

BSE 500

₹33,579.22

-0.39 (▲-132.39%)

Nifty Healthcare

₹13,681.30

-0.47 (▲-64.15%)

S&P BSE 150 MidCap

₹14,418.50

-0.56 (▲-81.33%)

S&P BSE 400 MidSmallCap

₹10,772.07

-0.52 (▲-56.71%)

Nifty Midcap 150

₹19,120.35

-0.29 (▲-55.05%)

S&P BSE SmallCap Select

₹6,954.89

0.04 (▲2.86%)

Nifty MidSmallcap 400

₹17,677.95

-0.2 (▲-36.15%)

BSE Small-Cap

₹46,638.13

-0.35 (▲-165.52%)

Nifty LargeMidcap 250

₹14,821.10

-0.33 (▲-48.35%)

BSE Healthcare

₹41,421.50

-0.12 (▲-48.19%)

S&P BSE AllCap

₹10,471.31

0.68 (▲71.07%)

Syngene International Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
52.74%
-3.63
Foreign Institutions
20.64%
-0.37
Mutual Funds
15.4%
13.46
Retail Investors
6.8%
0.91
Others
4.42%
4.12

Syngene International Ltd Key Indicators

Details20202021202220232024
Return On Equity %17.2816.1712.8913.6911.95
Details20202021202220232024
Return On Assets %9.78.136.967.788.55
Details20202021202220232024
Book Value Per Share (₹)54.470.5482.2890.13105.92
Details20202021202220232024
Earning Per Share (₹)10.310.129.8811.5712.69

Syngene International Ltd Valuation

Syngene International Ltd in the last 5 years

  • Overview

  • Trends

Lowest (23.09x)

March 31, 2020

Today (58.10x)

March 28, 2025

Industry (98.78x)

March 28, 2025

Highest (78.92x)

December 2, 2024

LowHigh

Syngene International Ltd Earnings and Dividends

  • Syngene International Ltd Earnings Results

    Syngene International Ltd’s net profit jumped 17.58% since last year same period to ₹131.10Cr in the Q3 2024-2025. On a quarterly growth basis, Syngene International Ltd has generated 23.56% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Syngene International Ltd Dividends April,2024

    In the quarter ending March 2024, Syngene International Ltd has declared dividend of ₹1.25 - translating a dividend yield of 0.34%.

    Read More about Dividends

Syngene International Ltd Technicals Summary

Bearish

Neutral

Bullish

Bullish

Syngene International Ltd is currently in a Bullish trading position according to technical analysis indicators.

More on Technical Analysis

Syngene International Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Syngene International Ltd
Syngene International Ltd
BUY₹29,232.24 Cr40.48%0.56₹510 Cr₹3,488 Cr
Sanofi India Ltd
Sanofi India Ltd
BUY₹13,185.60 Cr-1.69%0.52₹602 Cr₹2,851 Cr
Aurobindo Pharma Ltd
Aurobindo Pharma Ltd
BUY₹67,998.18 Cr36.18%0.56₹3,168 Cr₹29,001 Cr
Zydus Lifesciences Ltd
Zydus Lifesciences Ltd
HOLD₹89,192.58 Cr46.33%0.64₹3,854 Cr₹19,547 Cr
Abbott India Ltd
Abbott India Ltd
BUY₹65,281.17 Cr19.76%0.53NANA
See all

About Syngene International Ltd

Syngene International Limited is a India-based research, development, and manufacturing services organization driven by a team of 5200 scientists. It focuses primarily on the pharmaceutical and biotechnology sectors, and also provides services for nutrition, animal health, consumer goods, and other chemical sectors. The company’s health-related services extends across all major therapy areas and modalities. The operations are spread across 2 million sq. ft. with facilities at Bangalore, Hyderabad, and Mangalore. Syngene International Limited was incorporated in 1993 and consistently has entered into partnerships for research and development. This helped Syngene International cross an annual turnover of Rs 1000 crore in the year 2016. Over the years leading up to 2021, Syngene International expanded its research collaboration with companies such as Abbott, Bristol Myers Squibb, Herbalife, and Glaxo Smith Kline. It also commissioned new facilities and added bioreactors and microbial manufacturing capacity to strengthen biologics manufacturing. With investments in R&D and strengthening scientific capabilities, Syngene International continues to provide integrated drug discovery services.

Revenue: ₹943.70Cr as on December 2024 (Q4 24)
Net Profit: ₹131.10Cr as on December 2024 (Q4 24)
Listing date: 11 Aug, 2015
Chairperson Name: Kiran Mazumdar Shaw
OrganisationSyngene International Ltd
Headquarters
IndustryHealthcare
E-voting on sharesClick here to vote

FAQs on Syngene International Ltd

What is Syngene International Ltd price today?

Syngene International Ltd share price today stands at ₹726.2, Open: ₹724, Previous Close: ₹719.55, High: ₹731.8, Low: ₹716.3, 52 Week High: ₹960.6, 52 Week Low: ₹607.65.

How to Buy Syngene International Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Syngene International Ltd shares

What are today's traded volumes of Syngene International Ltd?

Today's traded volume of Syngene International Ltd(SYNGENE) is 5.48L.

What is today's market capitalisation of Syngene International Ltd?

Today's market capitalisation of Syngene International Ltd(SYNGENE) is ₹29232.24Cr.

What is the 52 Week High and Low Range of Syngene International Ltd?

Syngene International Ltd (SYNGENE)
Price
52 Week High
₹960.6
52 Week Low
₹607.65

How much percentage Syngene International Ltd is down from its 52 Week High?

Syngene International Ltd (SYNGENE) share price is ₹726.2. It is down -24.40% from its 52 Week High price of ₹960.6

How much percentage Syngene International Ltd is up from its 52 Week low?

Syngene International Ltd (SYNGENE) share price is ₹726.2. It is up 19.51% from its 52 Week Low price of ₹607.65